Custom Surgical Overview

  • Founded
  • 2019
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.31K
Latest Deal Amount
  • Investors
  • 3

Custom Surgical General Information


Manufacturer of medical devices intended to screen diseases of the eye by using a smartphone and optical system. The company's devices uses deep-learning and 3D printing which enables to capture high-quality images of the retina and provides diagnostic report of the disease based on images taken, enabling doctors to find it easy to detect and treat such diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • Balanstraße 73 Haus 10
  • At Plug and Play
  • 81541 Munich
  • Germany
+49 0177 0000000

Custom Surgical Timeline

Date FoundedFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Custom Surgical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 24-Mar-2020 $3.31K Completed Generating Revenue
2. Accelerator/Incubator 02-Mar-2020 00.000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Custom Surgical’s complete valuation and funding history, request access »

Custom Surgical Executive Team (3)

Name Title Board Seat Contact Info
Federico Acosta Founder and Chief Executive Officer
Harold Vallejo Chief Technology Officer
Maria Cristina Velescu Chief Marketing Officer
To view Custom Surgical’s complete executive team members history, request access »

Custom Surgical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jacobs University Bremen University 000 0000 000000 0
Xpreneurs Accelerator/Incubator 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator 000 0000 000000 0
To view Custom Surgical’s complete investors history, request access »